AUB vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals significant concerns, particularly the very weak Piotroski F-Score of 2/9, indicating poor financial health. While growth metrics are strong—especially 91.5% YoY revenue growth and 44.8% YoY EPS growth—profitability and valuation appear stretched relative to fundamentals. The stock trades near its 52-week high with a high current P/E of 19.53 despite a low forward P/E of 9.69, suggesting expectations of earnings improvement. However, missing earnings estimates in 13 of the last 25 quarters and lack of key financial health data (e.g., Altman Z-Score, Debt/Equity) create uncertainty, tempering bullish momentum.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
AUB vs JPM: Head-to-Head Comparison
This page compares Atlantic Union Bankshares Corporation (AUB) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.